Logo image
Identification of a novel human circulating metabolite of tenofovir disoproxil fumarate with LC-MS/MS
Journal article   Peer reviewed

Identification of a novel human circulating metabolite of tenofovir disoproxil fumarate with LC-MS/MS

Leanne C. Nye, Nicola Gray, Myra McClure, Marta Boffit, Elaine Holmes, Robert S. Plumb and Ian D. Wilson
Bioanalysis, Vol.7(6), pp.643-652
2015
PMID: 25871584
url
PublishedView
Published (Version of Record)

Abstract

Tenofovir disoproxil fumarate (TDF) is an antiretroviral drug used for the treatment of Human Immunodeficiency Virus and Hepatitis B infections. Results: A metabolite that has previously not been observed in the circulation of humans was detected by LC–MS/MS in early time point plasma samples following administration of TDF to healthy volunteers. The metabolite was identified using a range of LC–MS/MS-based techniques as a monoester of TDF, derived from the partially hydrolyzed bis-ester prodrug. TDF, when spiked into plasma, was observed to degrade first to the putative monoester and subsequently to tenofovir. Conclusion: The presence of this unstable metabolite in some samples has implications for sample collection, handling and storage in studies of tenofovir where serum concentrations are determined.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.66 HIV
1.66.1372 HIV Comorbidities
Web Of Science research areas
Biochemical Research Methods
Chemistry, Analytical
ESI research areas
Biology & Biochemistry
Logo image